Belize vs Europe (WHO region): New cases tested for RR-/MDR-TB
Belize
100.0%
in 2024
Europe (WHO region)
88.0%
in 2024
Belize rank
1st
Europe (WHO region) rank
3rd
New cases tested for RR-/MDR-TB over time
- Belize
- Europe (WHO region)
How they compare
Belize currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Belize's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 3 times across 15 shared years of data; in 2005 it was Europe (WHO region) ahead.
Belize ranks 1st and Europe (WHO region) ranks 3rd of 192 countries.
Across the 3 decades both report, Belize averaged higher in 1 and Europe (WHO region) in 2.
Head to head by decade
| Decade | Belize | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.6% | 50.0% | 49.4% | Europe (WHO region) |
| 2010s | 33.6% | 89.1% | 55.5% | Europe (WHO region) |
| 2020s | 91.2% | 90.8% | 0.4% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Belize or Europe (WHO region)?
- Belize, at 100.0% against 88.0% in Europe (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Belize and Europe (WHO region)?
- 12.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Europe (WHO region)?
- 15 years are reported by both, from 2005 to 2024.
- How do Belize and Europe (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Belize ranks 1st and Europe (WHO region) ranks 3rd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.